Goodwin

Jacob Osborn

Deals
7
Latest
Jun 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 7 deals
Deals by year
Jacob Osborn: deals by year0720252026 YTD: 7 M&A72026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Jacob Osborn was named on, most recent first
Jun 2026 MaintainX –AutodeskAcquisitionLegal adviser to MaintainX (target)Announced3,600.0Industrial Software+1Autodesk acquisition of MaintainX
Jun 2026 Vendr –Vertice TechnologyAcquisitionLegal adviser to Vendr (target)Announced–SaaS+1Vertice Technology acquisition of Vendr
May 2026 Dremio –SAP SEAcquisitionLegal adviser to Dremio (target)Announced–Software+2SAP SE acquisition of Dremio
Apr 2026 Tubulis EQT Life Sciences (LSP 7 fund)Gilead SciencesAcquisitionLegal adviser to Tubulis (target)Announced3,150.0Biotech+2Gilead Sciences acquisition of Tubulis
Mar 2026 Ouro Medicines –GileadAcquisitionLegal adviser to Ouro Medicines (target)Announced1,675.0Biotech+1Gilead acquisition of Ouro Medicines
Jan 2026 Fillex –Morrison Value Add IIStakeLegal adviser to Morrison (acquirer)Announced–Healthcare Services+1Morrison Value Add II stake in Fillex
Jan 2026 Ask Sage –BigBear.aiAcquisitionLegal adviser to Ask Sage (target)Completed250.0AIBigBear.ai acquisition of Ask Sage

Deals where Jacob Osborn is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.